Objective: To construct eukaryotic expression vectors using recombinant adenovirus containing the gene fragments encoding Her2/neu extracellular first ligand-binding domain (Her2-ECD), full-length extracellular domain (Her2-ECD), and extracellular and transmembrane domain (Her2-TM).
Methods: The cDNAs were amplified by RT-PCR and inserted into shuttle pAdTrack-CMV plasmids. Viral plasmids were obtained from homologous recombination in E. coli BJ5183, and transfected into 293 cells via liposome. Formation of viral plaque and expression of green fluorescent protein were observed by fluorescence microscopy, and the target proteins were detected by Western blotting.
Results: The target cDNA fragments were amplified by PCR with expected lengths and the DNA sequences were confirmed against Genbank. Formation of viral plaque, expression of green fluorescent protein and the target proteins were detected in 293 cells transfected by the viral plasmids, which showed elevated expression of Her2/neu protein with the increase of multiplicity of infection (MOI).
Conclusion: The eukaryotic expression vectors using recombinant adenovirus have been successfully constructed for expression of Her2/neu extracellular and transmembrane domains.
Download full-text PDF |
Source |
---|
Cancer Gene Ther
November 2024
National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
We previously developed an innovative strategy to induce CD8 T lymphocyte-immunity through in vivo engineering of extracellular vesicles (EVs). This approach relies on intramuscular injection of DNA expressing antigens of interest fused at a biologically-inactive HIV-1 Nef protein mutant (Nef). Nef is very efficiently incorporated into EVs, thus conveying large amounts of fusion proteins into EVs released by transfected cells.
View Article and Find Full Text PDFAsian Pac J Cancer Prev
June 2024
Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Unlabelled: The alterations of EGFR and HER2/neu as growth factor receptors and the cytoplasmic signal transduction proteins of RAS/RAF/MAP kinases including its end effector molecule (ERK) are important in the carcinogenesis of many tumors. The activation of these protooncogenes in prostate cancer is still under investigation. The aim of this work was to study EGFR, HER2- neu, inactive (non-phosphorylated) and active (phosphorylated) ERK expression in prostatic adenocarcinomas in correlation to the clinical and pathological parameters.
View Article and Find Full Text PDFIndian J Pathol Microbiol
February 2022
Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, SHUATS, Prayagraj, Uttar Pradesh, India.
Aim: : To assess HER2/neu expressions and correlate with E-cadherin and Serum HER2 level in gastric carcinoma.
Method: 31 gastric biopsies and 1 resected specimen were taken in the study with patient details and stained with H and E for histopathological details following Lauren's classification. Immunohistochemistry for HER2 and E-cadherin expression was conducted followed by serum HER2/neu ELISA.
Autops Case Rep
December 2020
Faculty Department of Oncosurgery, NH super-specialty Howrah, West Bengal, India.
Secretory carcinoma of the breast (SBC) is a rare breast neoplasm. Most of the patients present at an early stage with a relatively indolent clinical course. Lymph node and distant metastasis are also very infrequent.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!